Abstract:Jianwan Xie, 1, &ast Yanchu Li, 1, &ast Man Wang, 2, &ast Wenping He, 3 Xinxin Zhao 1 1 Department of Geriatric Medicine, Xuzhou No.1 People's Hospital, Xuzhou, 221002, People's Republic of China; 2 Medical Oncology, Xuzhou No.1 People's Hospital, Xuzhou, 221002, People's Republic of China; 3 Department of Pharmacy, Xuzhou No.1 People's Hospital, Xuzhou, 221002, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xinxin Zhao, Department of Geriatric Medicine, Xuzhou No.1 People's Hospital, 269 University Road, Xuzhou, 221002, People's Republic of China, Tel/Fax +86-0516-962011, Email Wenping He, Department of Pharmacy, Xuzhou No.1 People's Hospital, 269 University Road, Xuzhou, 221002, People's Republic of China, Email Purpose: Previous studies have shown that microRNA is involved in regulating a variety of human inflammatory diseases. The purpose of this study was to investigate the expression of miR-10a-3p in the blood of patients with severe pneumonia and evaluate its value in the diagnosis and prognosis of severe pneumonia. Patients and Methods: Seventy patients with severe pneumonia and 75 healthy individuals were included in this study. Venous blood of all subjects was obtained for RT-qPCR analysis to obtain the relative expression level of miR-10a-5p. The diagnostic accuracy of miR-10a-5p for severe pneumonia was assessed by ROC curve. After standardized treatment, the prognosis of patients with severe pneumonia was analyzed by a 28-day follow-up method. Kaplan–Meier curve and multivariate Cox regression analysis were used to determine the basic factors influencing the prognosis of patients. Results: Compared with healthy control, serum miR-10a-3p expression in patients with severe pneumonia was distinctly upregulated ( P < 0.001). Besides, ROC analysis showed that miR-10a-3p had high diagnostic accuracy for severe pneumonia, with an AUC of 0.881, sensitivity and specificity of 75.7% and 84.0%, respectively. Kaplan-Meier curve exhibited that high miR-10a-3p expression group had a higher probability of death than those with low miR-10a-3p expression. Multivariate Cox regression analysis demonstrated that miR-10a-3p and CRP were independent risk factors affecting the prognosis of patients. Conclusion: The expression of miR-10a-3p was increased in patients with severe pneumonia, and abnormally expressed miR-10a-3p has the potential to be used as a diagnostic and prognostic marker for severe pneumonia, which provides a new biological direction for the early detection and risk assessment of severe pneumonia. Keywords: severe pneumonia, miR-10a-3p, diagnosis, prognosis Severe pneumonia is an acute and critical disease of the respiratory system, with high morbidity and mortality. 1 Besides common pneumonia, it is often accompanied by obvious symptoms of poisoning. With the further deterioration of the disease, patients may be accompanied by septic shock, respiratory failure, etc., and even further develop into acute respiratory distress syndrome, encephalopathy or multiple organ dysfunction, which not only increases the burden of medical and health systems, but also brings huge socio-economic losses. 2 Therefore, the early identification and evaluation of the severity of pneumonia patients is of great significance for the rational allocation of medical resources, the formulation of appropriate treatment plans, the prevention of disease deterioration and the improvement of patients' prognosis. At present, many non-specific indicators may be related to the severity of severe pneumonia, such as C-reactive protein (CRP) and procalcitonin (PCT), but the specificity of these indicators is not enough to accurately reflect severe pneumonia. 3 Therefore, clinical research has always been one of the directions to seek accurate indicators for diagnosis and prognosis of severe pneumonia. MicroRNA (miRNA) is a kind of non-coding RNA which widely existing in eukaryotic cells. It can degrade mRNA, inhibit translation and protein synthesis, and regulate genes by binding to the 3'-untranslated regions (3'-UTR) of mRNA. 4,5 MiRNA has been proved to play an important role in biological growth and development of organisms, metabolism and the occurrence and development of diseases. 6 Studies have shown that miRNA can be released from cells and participate in inflammation and tissue damage. For example, Jiao et al reported that miR-30d-5p from neutrophil exosomes can induce sepsis-associated acute lung injury by activating the NF-κB signaling pathway. 7 Zaccagnini et al proved that the loss of miR- -Abstract Truncated-

MiR-103a-3p antagonism attenuates pneumonia via inactivating the PI3K/AKT/NF-κB signaling pathway by targeting PTEN

MicroRNA‑129 Plays a Protective Role in Sepsis‑induced Acute Lung Injury Through the Suppression of Pulmonary Inflammation Via the Modulation of the TAK1/NF‑κB Pathway.

MiR-103-3p Promotes Hepatic Steatosis to Aggravate Nonalcoholic Fatty Liver Disease by Targeting of ACOX1

Let7f‑5p Attenuates Inflammatory Injury in in Vitro Pneumonia Models by Targeting MAPK6.

let7f‐5p attenuates inflammatory injury in i n vitro pneumonia models by targeting MAPK6

Identification of Mirna Biomarkers of Pneumonia Using RNA-sequencing and Bioinformatics Analysis.

Deregulated Expression of miR-483-3p Serves as a Diagnostic Biomarker in Severe Pneumonia Children with Respiratory Failure and Its Predictive Value for the Clinical Outcome of Patients

MicroRNA-194 Regulates Lipopolysaccharide-Induced Cell Viability by Inactivation of Nuclear Factor-κ B Pathway.

Downregulation of TLR4 by Mir-181A Provides Negative Feedback Regulation to Lipopolysaccharide-Induced Inflammation

Microrna-22-3p Plays A Protective Role In A Murine Asthma Model Through The Inhibition Of The Nlrp3-Caspase-1-Il-1 Beta Axis

Downregulation Of Mir-199a-3p Mediated By The Ctbp2-Hdac1-Foxp3 Transcriptional Complex Contributes To Acute Lung Injury By Targeting Nlrp1

miRNA-206-3p alleviates LPS-induced acute lung injury via inhibiting inflammation and pyroptosis through modulating TLR4/NF-κB/NLRP3 pathway

Inhibition of miR-29b-1-5p Attenuates Inflammatory Response and Pulmonary Fibrosis in LPS-Induced Acute Lung Injury by Regulating RTN4 Expression

Long Non-Coding RNA (lncRNA) CRNDE Regulated Lipopolysaccharides (LPS)-Induced MRC-5 Inflammation Injury Through Targeting MiR-141

MicroRNA‑93 Contributes to the Suppression of Lung Inflammatory Responses in LPS‑induced Acute Lung Injury in Mice Via the TLR4/MyD88/NF‑κB Signaling Pathway.

Diagnostic and Prognostic Value of Dysregulated miR-10a-3p in Patients with Severe Pneumonia

Tracheal Epithelial Cell-Exosome-Derived Mir-21-5p Inhibits Alveolar Macrophage Pyroptosis to Resist Pulmonary Bacterial Infection Through PIK3CD-Autophagy Pathway

High Expression of Mir-222-3p in Children with Mycoplasma Pneumoniae Pneumonia

MiR-297 Alleviates LPS-induced A549 Cell and Mice Lung Injury Via Targeting Cyclin Dependent Kinase 8

MicroRNA (Mir)-429 Promotes Inflammatory Injury by Targeting Kruppel-Like Factor 4 (KLF4) in Neonatal Pneumonia.

RETRACTED: Inhibition of miR-29b-1-5p Attenuates Inflammatory Response and Pulmonary Fibrosis in LPS-Induced Acute Lung Injury by Regulating RTN4 Expression (Retracted Article)